Ledger.Open graph →
SEC Form D · Amendment · filed May 26, 2016

OncoResponse Inc

Offering
$28.2M
Sold
$19.5M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SEATTLE, WA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (17)

Wende Hutton · Seattle, WADirectorRuss Hawkinson · Seattle, WAExecKristine Swiderek · Seattle, WAExecSteve Gillis · Seattle, WADirectorClifford J. Stocks · Seattle, WAExec · DirectorRichard H. Coles · Grand Cayman, Cayman IslandsExec · DirectorJames Winokur · Stoneham, MADirectorChristopher Day · Grand Cayman, Cayman IslandsExecJose Larin · Yardley, PADirectorWen-Hui Chen · Grand Cayman, Cayman IslandsExecGeeta Vemuri · Deerfield, ILDirectorMichael P. Bourque · Stoneham, MADirectorDavid C. Manly · Stoneham, MAExecBrent K. Rentmeester · Stoneham, MAExec · DirectorMichael G. Clarke · Boston, MAExecGary A. Jacobs · Woburn, MADirectorGeeta Vemuri · New York, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗